Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, ...

Why is Secretary of State Marco Rubio allowing a crank who spews CCP propaganda to serve as a senior diplomat?

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the ...

Potent cannabis linked to surging schizophrenia cases - New schizophrenia cases linked to cannabis use disorder more than ...

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...

Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.

Explore the reality of schizophrenia by debunking seven myths and offering compassionate insights into this complex mental ...

The proportion of new schizophrenia cases linked to cannabis use has nearly tripled in almost two decades, increasing ...

The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...

A new Canadian study shows a tripling of schizophrenia cases linked to cannabis use disorder since the country legalized it.

Bristol Myers Squibb clocked $10 million in sales for new schizophrenia drug Cobenfy in the fourth quarter of 2024, with the ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...